The global infectious testing market is driven by rising incidence of infectious diseases such as HIV, hepatitis, tuberculosis, influenza, and emerging viral outbreaks. Growing demand for rapid diagnostic tests (RDTs), molecular diagnostics (PCR-based testing), and point-of-care testing technologies is fueling expansion. Increased healthcare infrastructure investment and government su... https://www.databridgemarketresearch.com/reports/global-infectious-testing-market